United States · FDA National Drug Code directory
Ciclopirox olamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-138_b7cbcb65-253b-4b79-a4b6-2f9de6bf0a4e
- Product NDC
- 45802-138
- Form
- CREAM
- Composition / generic term
- Ciclopirox olamine
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060719
- Source listing expiry
- 20271231
Source-listed ingredients
- CICLOPIROX OLAMINE — 7.7 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (45802-138-11) / 30 g in 1 TUBE · 45802-138-11
- 1 TUBE in 1 CARTON (45802-138-18) / 90 g in 1 TUBE · 45802-138-18
- 1 TUBE in 1 CARTON (45802-138-35) / 15 g in 1 TUBE · 45802-138-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →